This synergy is one of the main reasons why the no-DAC version is preferred over the DAC version in most research and clinical protocols that aim to maintain natural signaling patterns
Research is mixed or quite young on several ingredients, but it still has some potential
J Diabetes Res 2018:1232583 Ikonomidis I, Pavlidis G, Thymis J, Birba D, Kalogeris A, Kousathana F, Kountouri A, Balampanis K, Parissis J, Andreadou I, Katogiannis K, Dimitriadis G, Bamias A, Iliodromitis E, Lambadiari V (2020) Effects of glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors, and their combination on endothelial glycocalyx, arterial function, and myocardial work index in patients with type 2 diabetes mellitus after 12-month treatment
doi: 10.3390/biom12091246 9 BarnaB
Wang Y, Chen D, Xu D, Huang C, Xing R, He D, Xu H